» Articles » PMID: 31762622

Anti-inflammatory Activity of Species from Indonesia

Overview
Specialty Biology
Date 2019 Nov 26
PMID 31762622
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Anti-inflammatory drugs inhibit inflammation, particularly those classified as nonsteroidal anti-inflammatory drugs (NSAIDs). Several studies have reported that propolis has both anti-ulcerogenic and anti-inflammatory effects. In this study, we investigated the bioactive compound and anti-inflammatory properties of both smooth and rough propolis from . To further identify anti-inflammatory markers in propolis, LC-MS/MS was used, and results were analyzed by Mass Lynx 4.1. Rough and smooth propolis of . were microcapsulated with maltodextrin and arabic gum. Propolis microcapsules at dose 25-200 mg/kg were applied for carrageenan-induced rat's paw-inflammation model. Data were analyzed by one-way ANOVA and Kruskal-Wallis statistical tests. LC-MS/MS experiments identified seven anti-inflammatory compounds, including [6]-dehydrogingerdione, alpha-tocopherol succinate, adhyperforin, 6-epiangustifolin, deoxypodophyllotoxin, kurarinone, and xanthoxyletin. Our results indicated that smooth propolis at 50 mg/kg inhibited inflammation to the greatest extent, followed by rough propolis at a dose of 25 mg/kg. SPM and RPM with the dose of 25 mg/kg had inflammatory inhibition value of 62.24% and 58.12%, respectively, which is comparable with the value 70.26% of sodium diclofenac with the dose of 135 mg/kg. This study suggests that propolis has the potential candidate to develop as a non-steroid anti-inflammatory drug.

Citing Articles

New insights of propolis nanoformulation and its therapeutic potential in human diseases.

Kustiawan P, Syaifie P, Siregar K, Ibadillah D, Mardliyati E ADMET DMPK. 2024; 12(1):1-26.

PMID: 38560717 PMC: 10974817. DOI: 10.5599/admet.2128.


Sulawesi propolis induces higher apoptotic activity and lower inflammatory activity in a rat endometriosis model.

Situmorang H, Hestiantoro A, Purbadi S, Wuyung P, Werdhani R, Harahap A Eur J Obstet Gynecol Reprod Biol X. 2023; 19:100204.

PMID: 37753513 PMC: 10518513. DOI: 10.1016/j.eurox.2023.100204.


Recent Update on the Anti-Inflammatory Activities of Propolis.

Zulhendri F, Lesmana R, Tandean S, Christoper A, Chandrasekaran K, Irsyam I Molecules. 2022; 27(23).

PMID: 36500579 PMC: 9740431. DOI: 10.3390/molecules27238473.


Prognostic Roles of Inflammation- and Nutrition-Based Indicators for Female Patients with Cancer.

Yang M, Zhang Q, Ge Y, Tang M, Hu C, Wang Z J Inflamm Res. 2022; 15:3573-3586.

PMID: 35747251 PMC: 9211802. DOI: 10.2147/JIR.S361300.


In-vitro antioxidant, in-vivo anti-inflammatory, and acute toxicity study of Indonesian propolis capsule from s.

Farida S, Pratami D, Sahlan M, Laksmitawati D, Rohmatin E, Situmorang H Saudi J Biol Sci. 2022; 29(4):2489-2500.

PMID: 35531153 PMC: 9073061. DOI: 10.1016/j.sjbs.2021.12.034.


References
1.
Domiati S, El-Mallah A, Ghoneim A, Bekhit A, El Razik H . Evaluation of anti-inflammatory, analgesic activities, and side effects of some pyrazole derivatives. Inflammopharmacology. 2016; 24(4):163-72. DOI: 10.1007/s10787-016-0270-7. View

2.
Funakoshi-Tago M, Okamoto K, Izumi R, Tago K, Yanagisawa K, Narukawa Y . Anti-inflammatory activity of flavonoids in Nepalese propolis is attributed to inhibition of the IL-33 signaling pathway. Int Immunopharmacol. 2015; 25(1):189-98. DOI: 10.1016/j.intimp.2015.01.012. View

3.
Paulino N, Lemos Abreu S, Uto Y, Koyama D, Nagasawa H, Hori H . Anti-inflammatory effects of a bioavailable compound, Artepillin C, in Brazilian propolis. Eur J Pharmacol. 2008; 587(1-3):296-301. DOI: 10.1016/j.ejphar.2008.02.067. View

4.
Fullerton J, Gilroy D . Resolution of inflammation: a new therapeutic frontier. Nat Rev Drug Discov. 2016; 15(8):551-67. DOI: 10.1038/nrd.2016.39. View

5.
Shi H, Yang H, Zhang X, Sheng Y, Huang H, Yu L . Isolation and characterization of five glycerol esters from Wuhan propolis and their potential anti-inflammatory properties. J Agric Food Chem. 2012; 60(40):10041-7. DOI: 10.1021/jf302601m. View